Previous page
Table of Contents
| Previous page |
Table of Contents |
Next page |
In their Report, dated 12 February 1999 (Reporter, p. 392), the Faculty Board of Biology proposed a revision of the regulations for Part II (General) of the Medical and Veterinary Sciences Tripos, including a change in the title of the examination from Part II (General) to Part II. Subject to the approval of the recommendations of that Report, the Faculty Board of Biology now give notice, in accordance with Regulation 27 for the Medical and Veterinary Sciences Tripos, of the following subjects, and restrictions on combinations of subjects, for Part II in 2000.
Subject to any restrictions announced in a particular year by the Faculty Board under the provisions of Regulation 27(a), candidates are required to offer in the examination for Part II of the Medical and Veterinary Sciences Tripos:
| (a) | a combination of subjects comprising five written papers, provided that every candidate shall include among the subjects offered either one four-paper subject or at least one two-paper subject, and |
| (b) | a dissertation, which shall be submitted in accordance with the provisions of Regulation 29. |
All subjects make provision for candidates to offer a dissertation.
The subjects available for the examination in 2000 are listed below, together with the name of the Department offering the subject (which may be consulted for advice). If a minimum number of candidates is required before a subject can be offered, or if there is a limit on the number of candidates who can be accepted for a subject, this is indicated.
(a) Four-paper subjects Restrictions Department
| 301 | Mechanisms of Disease | max. 21 | Pathology |
| 302 | Pathology | Pathology | |
| 303 | Pharmacology | Pharmacology | |
| 304 | Psychology | max. 15 | Experimental Psychology |
(b) Two-paper subjects
| 201 | Behaviour and Veterinary Ethology | min. 6 | Zoology |
| 202 | Cellular and Molecular Pharmacology* | Pharmacology | |
| 203 | Cellular Pathology (Pathology A) | min. 6 | Pathology |
| 204 | Clinical Physiology and Neurobiology | Physiology | |
| 205 | Genetic Pathology (Pathology E) | min. 6 | Pathology |
| 206 | History of Medicine, Body and Mind | History and Philosophy of Science | |
| 207 | Human Genetics and Ecology | max. 5 | Biological Anthropology |
| 208 | Human Impact on the Environment | min. 2 | Zoology |
| 209 | Immunology (Pathology B) | min. 6 | Pathology |
| 210 | Microbial and Parasitic Disease (Pathology C) | min. 6 | Pathology |
| 211 | Pharmacology of Integrated Systems | Pharmacology | |
| 212 | Primate and Human Evolutionary Biology and Behaviour | max. 5 | Biological Anthropology |
| 213 | Vertebrate Evolution | min. 2, max. 6 | Zoology |
| 214 | Virology (Pathology D) | min. 6 | Pathology |
(c) One-paper subjects
| 101 | Biology of Parasitism | min. 4 | Clinical Veterinary Medicine |
| 102 | Conservation Biology | min. 2 | Zoology |
| 103 | Environmental Physiology | min. 2 | Zoology |
| 104 | Human Genetics and Variation | max. 5 | Biological Anthropology |
| 105 | Human Nutrition | min. 8 | Clinical Veterinary Medicine |
| 106 | Medical Aspects of Neurobiology | Physiology | |
| 107 | Medicine, Ethics, and Law | Genetics | |
| 108 | Medicine, Health, and Illness | Social and Political Sciences | |
| 109 | Topics in Clinical Physiology | Physiology |
* Cellular and Molecular Pharmacology (202) must be taken with Pharmacology of Integrated Systems (211)
Combinations of subjects are restricted for academic reasons, by overlapping lecture times, and by overlapping examination times. Impossible combinations are listed below.
In the following table a subject in column (1) may not be combined with any subject listed on the corresponding line of any of columns (2), (3), and (4).
| (1) | (2) | (3) | (4) | |
|---|---|---|---|---|
| Four-paper subjects | Two-paper subjects | One-paper subjects | ||
| 301 | Mechanisms of Disease | 302, 303, 304 | 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214 | 103, 106, 108, 109 |
| 302 | Pathology | 301, 303, 304 | 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214 | 101, 102, 103, 104, 108 |
| 303 | Pharmacology | 301, 302, 304 | 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214 | 104, 108, 109 |
| 304 | Psychology | 301, 302, 303 | 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214 | 101, 102, 103, 104, 105, 106, 108, 109 |
| 201 | Behaviour and Veterinary Ethology | 301, 302, 303, 304 | 202, 203, 205, 207, 211 | 104, 108 |
| 202 | Cellular and Molecular Pharmacology | 301, 302, 303, 304 | 201, 203, 204, 205, 206, 207, 208, 209, 210, 212, 213, 214 | 104, 109 |
| 203 | Cellular Pathology (Pathology A) | 301, 302, 303, 304 | 201, 202, 205, 207, 209, 210, 214 | 104 |
| 204 | Clinical Physiology and Neurobiology | 301, 302, 303, 304 | 202, 212, 213 | 103, 106, 109 |
| 205 | Genetic Pathology (Pathology E) | 301, 302, 303, 304 | 201, 202, 203, 207, 209, 210, 214 | 104 |
| 206 | History of Medicine, Body and Mind | 301, 302, 303, 304 | 202, 207, 212 | 105 |
| 207 | Human Genetics and Ecology | 301, 302, 303, 304 | 201, 202, 203, 205, 206, 212 | 104, 105, 108 |
| 208 | Human Impact on the Environment | 301, 302, 303, 304 | 202, 214 | 101, 102, 108 |
| 209 | Immunology (Pathology B) | 301, 302, 303, 304 | 202, 203, 205, 210, 214 | 103 |
| 210 | Microbial and Parasitic Disease (Pathology C) | 301, 302, 303, 304 | 202, 203, 205, 209, 211, 214 | 108 |
| 211 | Pharmacology of Integrated Systems | 301, 302, 303, 304 | 201, 210 | 108 |
| 212 | Primate and Human Evolutionary Biology and Behaviour | 301, 302, 303, 304 | 202, 204, 206, 207, 213 | 103, 104, 109 |
| 213 | Vertebrate Evolution | 301, 302, 303, 304 | 202, 204, 212 | 103, 109 |
| 214 | Virology (Pathology D) | 301, 302, 303, 304 | 202, 203, 205, 208, 209, 210 | 101, 102, 108 |
| 101 | Biology of Parasitism | 302, 304 | 208, 214 | 102, 108 |
| 102 | Conservation Biology | 302, 304 | 208, 214 | 101, 108 |
| 103 | Environmental Physiology | 301, 302, 304 | 204, 209, 212, 213 | 106 |
| 104 | Human Genetics and Variation | 302, 303, 304 | 201, 203, 205, 207, 212 | |
| 105 | Human Nutrition | 304 | 206, 207 | 108 |
| 106 | Medical Aspects of Neurobiology | 301, 304 | 204 | 103 |
| 107 | Medicine, Ethics, and Law | 108 | ||
| 108 | Medicine, Health, and Illness | 301, 302, 303, 304 | 201, 207, 208, 210, 211, 214 | 101, 102, 105, 107 |
| 109 | Topics in Clinical Physiology | 301, 303, 304 | 202, 204, 212, 213 | |
Candidates and their advisers are asked to note that the reference numbers used in this Notice are those notified to Colleges in the Lent Term as part of the procedure for admission to restricted subjects. The code numbers to be used for examination entries, which will follow a different system, will be issued by the Board of Examinations in the Michaelmas Term.
| Previous page |
Table of Contents |
Next page |
Cambridge University Reporter, 17 March 1999
Copyright © 1999 The Chancellor, Masters and Scholars of the University of Cambridge.